Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis (Q65471955)

From Wikidata
Jump to navigation Jump to search
clinical trial
edit
Language Label Description Also known as
English
Efficacy in Reducing Fractures and Safety of Zoledronic Acid in Men With Osteoporosis
clinical trial

    Statements

    A Two Year Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group Study to Evaluate the Fracture Efficacy and Safety of Intravenous Zoledronic Acid 5 mg Annually for the Treatment of Osteoporosis in Men (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    0 references
    December 2006
    0 references
    October 2010
    0 references
    1,199
    0 references
    0 references
    50 year
    0 references
    85 year
    0 references

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit